The FY 2026 federal budget draft includes a proposal to defund the State Health Insurance Assistance Program (SHIP), which provides vital Medicare enrollment and counseling services to nearly 2 million beneficiaries annually.
Ascension and Blue Cross Blue Shield Illinois report healthcare data breaches; Atrium Health wins hospital expansion in NC; Elevance Health cuts Medicare Advantage marketing amid legal challenges; Sutter Health settles antitrust lawsuit; AI used to reduce clinical burnout.
Centene reports strong Q1 2025 financial results with earnings growth, expanded Medicaid and Medicare membership, and raised revenue guidance. Strategic contract renewals support its market expansion in government-sponsored healthcare programs.
The DOJ's inquiries into medical journals, a Supreme Court case on ACA preventive coverage, and the CDC contraceptive guideline team's elimination impact U.S. insurance, healthcare regulation, and clinical practice.
The U.S. Supreme Court is expected to uphold the ACA's free preventive care mandate, influencing health insurance coverage and regulatory authority of the HHS Secretary.
Pharmaceutical companies increased consumer-directed drug advertising by nearly 30% in early 2025, leveraging tax deductions that affect prescription drug prices, according to AHIP and CSRxP analyses.
The SEC prevails in a regulatory case against a Massachusetts investment advisor accused of earning fraudulent commissions on annuities sales, affirming oversight over advisors selling insurance products.
The California FAIR Plan sees a surge in wildfire claims and policyholders after LA fires amid private insurer withdrawals, facing financial strain and legal scrutiny.
Swiss Re appoints Bernhard Kaufmann as group chief risk officer effective October 2025, along with board re-elections and strategic exit from Asia-Pacific life insurance operations.
Admiral Group plans to sell its U.S. auto insurance subsidiary Elephant Insurance to investment firm J.C. Flowers, pending regulatory approval, with completion expected by Q4 2025.
